Cardiome Pharma Corp ($COM) - buy or sell? Stock discussion, ideas, forum

Cardiome Pharma Corp

Cardiome Pharma Corp.

Industry: Consumer, Non-cyclical

Ticker	Exchange	ISIN
$COM	TSX	CA14159U3010

Recent news

Kinaxis Inc Net Income dropped on 41.2% while Revenue surged on 17.0%

B2Gold Corp reports 114% Net Income growth in 2020 and 11.0 pp EBITDA Margin growth from 65.6% to 76.6%

Tucows Inc reports 35.8% EBITDA decline in 2020 and 7.7% Revenue decline

KFG Resources Ltd reports 23.7% revenue decline in FY2020 and 25.1 pp EBITDA Margin decline from -3.5% to -28.6%

EXFO Inc EBITDA dropped on 30.3% and Revenue decreased on 7.4%

Arctic Hunter Energy Inc revenue decline accelerated to 47.8% in FY2020 vs. 37.7% a year earliner

Canyon Creek Food Co Ltd reports 38.5% revenue growth in FY2020 and 0.53 pp EBITDA Margin decline from -13.1% to -13.7%

Orbit Garant Drilling Inc Debt surged on 39.8% and Net Debt / EBITDA surged on 1.1x from 3.0x to 4.1x

Rochester Resources Ltd revenue returned to growth in FY2020: increased 13.2% vs. 19.2% decline a year earliner

Quizam Media Corp reports 8.0% revenue decline in FY2020 and 80.7 pp EBITDA Margin growth from -265% to -184%

Twit about COM stock

Share your investment idea or question on Cardiome Pharma Corp stock:

Latest twits on Cardiome Pharma Corp (COM)

No twits yet. Be the first to post!

Have a question about COM? Ask and other investors will be eager to help you.

Have an idea about COM? Share it with other investors.

Cardiome Pharma Corp news

07.03.2017 Cardiome Pharma Corp reports 20.8% revenue growth in FY2016

10.03.2016 Cardiome Pharma Corp revenue started to decline in 2015: dropped 30.4% vs. 566% growth a year earliner

Cardiome Pharma Corp stock price chart

Cardiome Pharma Corp financials

mln. $	FY2010	FY2011	FY2012

Revenue	66.064	1.505	0.789
EBITDA	0.000	0.000	0.000
Net income	35.499	-27.920	-18.315
CAPEX	0.274	0.676	0.141
Debt	25.000	25.000	32.500
Cash	76.888	48.644	41.267

Cardiome Pharma Corp news

07.03.2017 Cardiome Pharma Corp reports 20.8% revenue growth in FY2016

10.03.2016 Cardiome Pharma Corp revenue started to decline in 2015: dropped 30.4% vs. 566% growth a year earliner

About Cardiome Pharma Corp

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with clinical drug programs. The Company's programs focus on atrial arrhythmia and congestive heart failure.